Lupin Releases Rivaroxaban Pills in the US that have FDA Approval
After receiving final clearance from the US Food and Drug Administration (USFDA) for its (ANDA), Lupin announced the availability of Rivaroxaban tablets USP, 2.5 mg, in the US market. The recently released medication is bioequivalent to 2.5 mg of Janssen Pharmaceuticals, Inc.’s Xarelto. In patients with (PAD), including those who have had lower extremity revascularization…